InvestorsHub Logo
Followers 7
Posts 484
Boards Moderated 0
Alias Born 03/03/2014

Re: None

Wednesday, 06/04/2014 4:35:54 PM

Wednesday, June 04, 2014 4:35:54 PM

Post# of 144814
HERE IS MY OBSERVATION ON NUVILEX:
The recent deal with Chardan is not necessarily a great deal for the long term. I do not believe NVLX planning for the long term. They are seeking FDA approval for their pancreatic cancer drug treatment (ONE OF THE MOST TRICKY OF ALL CANCERS).They are also being very strategic on the time frame they apply for orphan drug designation, also starting to gather some pre-clinical data on Ciab for the use of diabetes. The combination of those things plus a few other variables Just really signal a buyout in my opinion. Nuvilex is trying to get together some rock solid data together to further there position for a buyout. All my opinion. Anyone else have anything to ad?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News